BAD and neuroblastoma: In the human neuroblastoma cell line (SH-SY5Y), EGCG at low concentration (1 μM) impacted on BCL2 associated agonist of cell death (Bad) levels, while the protein kinase C (PKC) inhibitor GF109203X impeded Bad degradation [169].